Analyst Reco. Simcere Pharmaceutical Group Limited

Equities

Delayed Hong Kong S.E. Other stock markets 07:46:13 02/05/2024 am IST			5-day change	1st Jan Change
5.43 ^HKD	+0.56%		+4.02%	-19.32%

25/04	Simcere Pharmaceutical’ Profit Down 23% in 2023	MT
10/04	Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA	MT

UBS Adjusts Simcere Pharmaceutical’s Price Target to HK$13 From HK$12.50, Keeps at Buy	05/22/05	MT
UBS Adjusts Simcere Pharmaceutical’s Price Target to HK$12.50 From HK$11.80, Keeps at Buy	30/22/30	MT
SIMCERE PHARMACEUTICAL : Nomura Starts Simcere Pharmaceutical Group at Buy With HK$10.1 Price Target	19/21/19	MT

No results for this search